Status: current, Defined. Date: 31-Jul 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3026651000168119 | Anzemet 12.5 mg/0.625 mL injection, 6 x 0.625 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 3047491000168114 | Anzemet (dolasetron mesilate monohydrate 12.5 mg / 0.625 mL) injection, 6 x 0.625 mL vials (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3087621000168116 | Anzemet (dolasetron mesylate monohydrate 12.5 mg / 0.625 mL) injection, 6 x 0.625 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Anzemet 12.5 mg/0.625 mL injection, 6 x 0.625 mL vials | has TP | Anzemet | true | Inferred relationship | Some | ||
| Anzemet 12.5 mg/0.625 mL injection, 6 x 0.625 mL vials | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Anzemet 12.5 mg/0.625 mL injection, 6 x 0.625 mL vials | Is a | Anzemet 12.5 mg/0.625 mL injection, 6 x 0.625 mL vials | true | Inferred relationship | Some | ||
| Anzemet 12.5 mg/0.625 mL injection, 6 x 0.625 mL vials | has container type | vial | true | Inferred relationship | Some | ||
| Anzemet 12.5 mg/0.625 mL injection, 6 x 0.625 mL vials | has TPUU | Anzemet 12.5 mg/0.625 mL injection, 0.625 mL vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR